1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Honz Pharmaceutical Co., Ltd.

Honz Pharmaceutical Co., Ltd.

300086.SZ
Honz Pharmaceutical Co., Ltd.CN flagShenzhen Stock Exchange
6.51
CNY
-0.08
- -
2.96BMarket Cap

Total Valuation

Honz Pharmaceutical Co., Ltd. carries a market capitalization of 2.96B, placing it among publicly traded companies globally. Its enterprise value stands at 4.19B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.96B
Enterprise Value4.19B

Share Statistics

Honz Pharmaceutical Co., Ltd. currently has 455.12M shares outstanding.

Shares Outstanding455.12M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 10.52, and the price-to-book ratio stands at -49.29.

PE RatioN/A
PS Ratio10.52
PB Ratio-49.29
P/TBV Ratio4.64
P/FCF Ratio221.26
P/OCF RatioN/A

Enterprise Valuation

EV / Sales11.75
EV / EBITDAN/A
EV / EBITN/A
EV / FCF145.95

Financial Position

Honz Pharmaceutical Co., Ltd. maintains a current ratio of 0.50, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 47.79, indicating elevated leverage, while an interest coverage ratio of -8.38 demonstrates limited ability to service its debt obligations.

Current Ratio0.50
Quick Ratio0.03
Debt / Equity47.79
Debt / EBITDA-4.16
Interest Coverage-8.38

Financial Efficiency

Return on Equity (ROE)-81.83
Return on Assets (ROA)-10.11
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.91

Taxes

Income Tax-11.79M
Effective Tax RateN/A

Stock Price Statistics

Honz Pharmaceutical Co., Ltd.'s stock has gained approximately 17.2973% over the past 52 weeks. The 50-day moving average sits at 6.76, while the 200-day moving average is 8.83.

Beta (5Y)N/A
52-Week Price Change17.2973%
50-Day Moving Average6.76
200-Day Moving Average8.83
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Honz Pharmaceutical Co., Ltd. generated 356.35M in revenue and converted that into -189.67M in net income, yielding earnings per share of -0.42. EBITDA reached -104.44M, while operating income came in at -104.44M.

Revenue356.35M
Gross Profit204.30M
Operating Income-104.44M
Pretax Income-204.69M
Net Income-189.67M
EBITDA-104.44M
EBIT-104.44M
Earnings Per Share (EPS)-0.42

Balance Sheet

Honz Pharmaceutical Co., Ltd. holds 17.27M in cash and equivalents against 434.46M in total debt, resulting in a net debt position of 318.10M. Total book value stands at -76.04M, with working capital of -273.68M providing operational flexibility.

Cash & Cash Equivalents17.27M
Total Debt434.46M
Net Debt318.10M
Equity (Book Value)-76.04M
Book Value Per Share-0.17
Working Capital-273.68M

Cash Flow

After subtracting -16.94M in capital expenditures, free cash flow totaled -16.94M - equivalent to -0.04 per share.

Operating Cash FlowN/A
Capital Expenditures-16.94M
Free Cash Flow-16.94M
FCF Per Share-0.04

Margins

Honz Pharmaceutical Co., Ltd. operates with a gross margin of 57.33, reflecting its pricing power and cost economics. The operating margin of -29.31 and net profit margin of -53.23 provide insight into operational efficiency.

Gross Margin57.33
Operating Margin-29.31
Pretax Margin-57.44
Profit Margin-53.23
EBITDA Margin-29.31

Dividends & Yields

The company's payout ratio of -5.78 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.02
Dividend YieldN/A
Payout Ratio-5.78
Shareholder Yield2.44
FCF Yield0.45

Stock Splits

Honz Pharmaceutical Co., Ltd.'s most recent stock split took place on September 30, 2015 with a 2:3 split ratio.

Last Split Date9/30/2015
Split Ratio2:3

Scores

Honz Pharmaceutical Co., Ltd. posts an Altman Z-Score of 2.07, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.07